QLI - Qilian International Market Capitalization

Corporate emblem and logo of Qilian International Holding Group Limited (QLI)

The growth of Qilian International (QLI) is driven by the demand for Chinese medicine and agrochemicals, fueled by plant upgrades and expansion across Asia. Business success is constrained by PRC government control and raw material costs, while the market capitalization stands at 0.19. Historical price action clearly demonstrates the asset's market volatility. Steady interest in medical research transforms the company into a defensive asset, independent of global macroeconomic trends.

QLI qlsyy.net: Market Valuation in the range 07/04/2022 - 08/17/2024

Metric breakdowns and analytics for Qilian International Corp (QLI)

Summary company analysis:QLI (Qilian International Holding)
Product sample of Qilian International

The market capitalization dynamics of Qilian International (QLI) reflect investment expectations regarding the development of the pharmaceutical ecosystem in China. This indicator represents the aggregate result of discounting the issuer's future cash flows. The calculation is based on the product of the current share price and the total number of shares outstanding. For a business with limited capacity expansion due to environmental oversight, this metric measures the market margin of safety. High values confirm the capital's resilience to macroeconomic shocks.

Competitors of Qilian International (QLI)

Market Value Haleon HLN|Kenvue Inc - Market Value|Verona Pharma Corp - Market Capitalization|Market Capitalization Jyong Bio MENS|Ligand Pharmaceuticals (LGND) - Market Value|Market Valuation AMRX (amneal.com)|PRGO (Perrigo) - Market Capitalization|ALVO: Market Value|Market Capitalization LQDA|Market Capitalization Galapagos Corp (GLPG)|Market Value ANI Pharmaceuticals ANIP|Market Value MNKD|AMPH - Market Value|Pacira Pharmaceuticals (PCRX) - Market Valuation|SPRY: Market Capitalization|Theravance Corp (TBPH) - Market Capitalization|Market Valuation AQST|SCPH: Market Value|Market Value Tectonic Therapeutic, Inc. (TECX)|TNXP - Market Value|China SXT Pharmaceuticals, Inc. - Market Valuation|Market Value EPRX (Eupraxia Pharmaceuticals, Inc.)|BioHarvest Sciences - Market Capitalization|Market Value EXOZ (invizyne.com)|ORMP: Market Capitalization|Market Value Entera Bio (ENTX)|Market Value MindWalk|ABVC: Market Value|Market Value Cumberland Pharmaceuticals (CPIX)|quantumbiopharma.com (QNTM) - Market Capitalization|Market Capitalization FGEN (FibroGen)|Market Capitalization Telomir Pharmaceuticals Inc (TELO)|RANI - Market Value|SNYR: Market Value|RLYB: Market Capitalization|LEXX - Market Capitalization|PULM (Pulmatrix) - Market Capitalization|Market Capitalization Pheton|Market Value Aptorum Group Limited (APM)|Lyra Therapeutics Inc - Market Capitalization|Impact BioMedical - Market Valuation|Market Value TNFA|cbdMD Corp - Market Capitalization|Market Capitalization PainReform Ltd PRFX|altamiratherapeutics.com (CYTO) - Market Value|Market Capitalization LIPO|Market Valuation OPTN|PIRS (pieris.com) - Market Value|Market Capitalization PROC|PTPI - Market Value|Market Value ACELYRIN, Inc. SLRN|Market Value TFFP